HALO · Halozyme Therapeutics, Inc.
$98.66
-2.01 (-2.00%)
At close · Aug 14
Market Cap
$11.20B
Shares
113.50M
Weekly off-exchange (dark pool / OTC) trading volume reported to FINRA under its OTC/ATS Transparency data. ATS volume is executed on alternating trading systems (dark pools); non-ATS OTC is other over-the-counter dealer volume. The off-exchange share is total off-exchange volume as a percentage of consolidated weekly trading volume for the same Monday–Friday week.
Off-Exchange Volume History
| Week Start | ATS Volume | Non-ATS OTC Volume | Total Off-Exchange | % of FINRA Weekly Volume |
|---|---|---|---|---|
| 2026-07-06 | 2,928,440 | 1,688,026 | 4,616,466 | 44.9% |
| 2026-06-29 | 1,866,205 | 1,497,661 | 3,363,866 | 44.7% |
| 2026-06-22 | 1,978,447 | 2,731,623 | 4,710,070 | 46.9% |
| 2026-06-15 | 1,583,251 | 1,313,001 | 2,896,252 | 32.2% |
| 2026-06-08 | 1,641,753 | 1,456,279 | 3,098,032 | 43.3% |
| 2026-06-01 | 2,209,397 | 1,412,701 | 3,622,098 | 37.4% |
| 2026-05-25 | 1,314,768 | 2,022,702 | 3,337,470 | 46.4% |
| 2026-05-18 | 1,716,585 | 2,052,751 | 3,769,336 | 46.2% |
| 2026-05-11 | 3,921,102 | 3,160,843 | 7,081,945 | 48.6% |
| 2026-05-04 | 1,724,778 | 987,690 | 2,712,468 | 40.8% |
| 2026-04-27 | 1,751,792 | 1,205,359 | 2,957,151 | 49.3% |
| 2026-04-20 | 1,941,153 | 1,176,586 | 3,117,739 | 42.1% |
| 2026-04-13 | 1,870,837 | 1,730,420 | 3,601,257 | 52.0% |
| 2026-04-06 | 1,980,484 | 1,091,803 | 3,072,287 | 46.2% |
| 2026-03-30 | 1,225,059 | 2,224,893 | 3,449,952 | 55.5% |
| 2026-03-23 | 1,535,198 | 1,032,563 | 2,567,761 | 42.4% |
| 2026-03-16 | 1,954,974 | 2,276,994 | 4,231,968 | 46.7% |
| 2026-03-09 | 2,107,606 | 1,184,440 | 3,292,046 | 42.2% |
| 2026-03-02 | 2,126,522 | 1,874,884 | 4,001,406 | 46.1% |
| 2026-02-23 | 1,826,933 | 1,121,618 | 2,948,551 | 39.9% |
| 2026-02-16 | 3,280,129 | 2,228,694 | 5,508,823 | 40.3% |
| 2026-02-09 | 1,930,765 | 1,492,149 | 3,422,914 | 40.4% |
| 2026-02-02 | 3,462,587 | 2,788,884 | 6,251,471 | 47.4% |
| 2026-01-26 | 2,415,972 | 1,430,668 | 3,846,640 | 42.0% |
| 2026-01-19 | 1,148,721 | 1,009,449 | 2,158,170 | 46.6% |
| 2026-01-12 | 1,482,391 | 1,248,871 | 2,731,262 | 38.1% |
| 2026-01-05 | 3,058,799 | 4,190,358 | 7,249,157 | 51.1% |
| 2025-12-29 | 1,176,998 | 1,432,916 | 2,609,914 | 49.3% |
| 2025-12-22 | 869,141 | 682,288 | 1,551,429 | 40.5% |
| 2025-12-15 | 1,767,589 | 2,815,648 | 4,583,237 | 42.1% |
| 2025-12-08 | 4,184,583 | 2,987,597 | 7,172,180 | 43.3% |
| 2025-12-01 | 3,187,092 | 2,311,612 | 5,498,704 | 43.1% |
| 2025-11-24 | 1,599,138 | 3,306,597 | 4,905,735 | 46.6% |
| 2025-11-17 | 1,876,529 | 2,002,293 | 3,878,822 | 46.5% |
| 2025-11-10 | 2,163,479 | 3,803,455 | 5,966,934 | 51.9% |
| 2025-11-03 | 3,213,905 | 10,782,389 | 13,996,294 | 67.8% |
| 2025-10-27 | 1,671,446 | 1,036,461 | 2,707,907 | 38.6% |
| 2025-10-20 | 1,410,051 | 1,858,024 | 3,268,075 | 47.2% |
| 2025-10-13 | 2,494,084 | 2,057,185 | 4,551,269 | 44.2% |
| 2025-10-06 | 2,231,100 | 2,539,447 | 4,770,547 | 46.0% |
| 2025-09-29 | 3,208,517 | 3,319,246 | 6,527,763 | 48.1% |
| 2025-09-22 | 2,055,464 | 2,806,694 | 4,862,158 | 47.4% |
| 2025-09-15 | 1,841,844 | 2,142,059 | 3,983,903 | 33.7% |
| 2025-09-08 | 2,051,958 | 1,836,161 | 3,888,119 | 50.4% |
| 2025-09-01 | 1,834,585 | 2,663,480 | 4,498,065 | 47.3% |
| 2025-08-25 | 1,957,822 | 2,802,728 | 4,760,550 | 48.7% |
| 2025-08-18 | 2,365,934 | 3,711,541 | 6,077,475 | 55.0% |
Showing 1–47 of 47 weeks
Key facts
CIK
1159036
CUSIP
40637H109
13F (30d)
595 filings
579 filers
Visit website
Investor relations